Konstantin Byrgazov

Konstantin Byrgazov is a seasoned clinical scientist with extensive experience in oncology and translational research. Currently serving as Senior Clinical Scientist and Associate Director at Galapagos since November 2023, Konstantin has held significant roles including Associate Clinical Development Director at Novartis and Translational and Clinical Research Director at Oncopeptides AB. Previous positions also include a Senior Scientist role at the Children's Cancer Research Institute and various academic responsibilities at the University of Vienna. Konstantin holds a PhD in Molecular Biology from the University of Vienna, complemented by business-focused education from Harvard Business School, IESE Business School, and BioBusiness Summer School. Early career experiences include roles at Rosneft, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, and Gazpromneft-NTC.